Espejo-Román, J.M.; Rubio-Ruiz, B.; Cano-Cortés, V.; Cruz-López, O.; Gonzalez-Resines, S.; Domene, C.; Conejo-GarcÃa, A.; Sánchez-MartÃn, R.M.
Selective Anticancer Therapy Based on a HA-CD44 Interaction Inhibitor Loaded on Polymeric Nanoparticles. Pharmaceutics 2022, 14, 788.
https://doi.org/10.3390/pharmaceutics14040788
AMA Style
Espejo-Román JM, Rubio-Ruiz B, Cano-Cortés V, Cruz-López O, Gonzalez-Resines S, Domene C, Conejo-GarcÃa A, Sánchez-MartÃn RM.
Selective Anticancer Therapy Based on a HA-CD44 Interaction Inhibitor Loaded on Polymeric Nanoparticles. Pharmaceutics. 2022; 14(4):788.
https://doi.org/10.3390/pharmaceutics14040788
Chicago/Turabian Style
Espejo-Román, José M., Belén Rubio-Ruiz, Victoria Cano-Cortés, Olga Cruz-López, Saúl Gonzalez-Resines, Carmen Domene, Ana Conejo-GarcÃa, and Rosario M. Sánchez-MartÃn.
2022. "Selective Anticancer Therapy Based on a HA-CD44 Interaction Inhibitor Loaded on Polymeric Nanoparticles" Pharmaceutics 14, no. 4: 788.
https://doi.org/10.3390/pharmaceutics14040788
APA Style
Espejo-Román, J. M., Rubio-Ruiz, B., Cano-Cortés, V., Cruz-López, O., Gonzalez-Resines, S., Domene, C., Conejo-GarcÃa, A., & Sánchez-MartÃn, R. M.
(2022). Selective Anticancer Therapy Based on a HA-CD44 Interaction Inhibitor Loaded on Polymeric Nanoparticles. Pharmaceutics, 14(4), 788.
https://doi.org/10.3390/pharmaceutics14040788